NAVIDEA BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 101-125 of 949 matching filings.

Per page
25
Current page
5
SC 13D/A File 005-43603

SC 13D/A

Filing date
12 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Sep 2022
Reporting date
30 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Sep 2022
Reporting date
30 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Sep 2022
Reporting date
31 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Sep 2022
Reporting date
31 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-262691

FORM 424B3

Filing date
18 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-262691

FORM 424B4

Filing date
04 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262691

EFFECT filing

Filing date
03 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-262691

FORM S-1/A

Filing date
02 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Aug 2022
Reporting date
31 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Aug 2022
Reporting date
31 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Aug 2022
Reporting date
31 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Aug 2022
Reporting date
31 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-262691

FORM FWP

Filing date
22 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-262691

FORM S-1/A

Filing date
20 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-262691

FORM S-1/A

Filing date
01 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jun 2022
Reporting date
31 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jun 2022
Reporting date
31 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .